Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder

ClinicalTrials.gov ID: NCT00060905

Public ClinicalTrials.gov record NCT00060905. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and effectiveness of Depakote ER compared to placebo in the treatment of bipolar disorder, manic or mixed type in adults.

Study identification

NCT ID
NCT00060905
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
370 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2002
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 3, 2006

Started 2003

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
Comprehensive Neuroscience of SCA Cerritos California 90703
AVI Clinical Research Torrance California 90505
Washington Hospital Center Washington D.C. District of Columbia 20010
Mark Lerman, MD Hoffman Estates Illinois 60194
University of Louisville Bipolar Research Program Louisville Kentucky 40202
Brentwood Research Inst. Shreveport Louisiana 71101
Centers for Behavioral Health, LLC Rockville Maryland 20850
McLean Hospital Belmont Massachusetts 02478
Pioneer Research Baltimore Michigan 48047
University of Mississippi Medical Center Jackson Mississippi 39216
Steven A. Glass, MD Clementon New Jersey 08021
The Holliswood Hospital Holliswood New York 11423
NYU School of Medicine - Bellevue New York New York 10016
MetroHealth Medical Center Cleveland Ohio 44109
UT Mental Sciences Institute Houston Texas 77030
San Antonio State Hospital San Antonio Texas 78223
CNS of Northern Virginia Falls Church Virginia 22041
VAMC Milwaukee Wisconsin 53295

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00060905, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 3, 2006 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00060905 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →